by QA Validation Engineer | Feb 23, 2016 | Novartis
Doctors pounce on ‘alarmist,’ ‘horrifying’ Novartis heart-failure ad The TV ad and accompanying print work have prompted criticism from doctors, including the cardiologist, Milton Packer, who headed up a key trial testing Novartis’ new... by QA Validation Engineer | Feb 18, 2016 | Novartis
Novartis And the Future Of Drug Pricing Novartis is bucking that convention by agreeing to let insurers Cigna and Aetna pay different prices for its heart-failure drug, Entresto, based on how it performs. This is not the first or only such deal, but they are rare in... by QA Validation Engineer | Feb 7, 2016 | Novartis
Novartis slammed for ‘alarmist’ ad for heart failure drug The campaign, however, does not specifically mention Entresto, a Novartis drug that was approved last summer by US regulators to prevent heart failure, which is a common malady that afflicts about... by QA Validation Engineer | Apr 22, 2015 | Pharmaceutical Validation Blog
Omnicell, Inc. Closes Acquisition of Germany-based MACH4 Pharma Systems MACH4” s highly automated medication management systems are installed in a base of over 1,000 retail and health center drug store customers mainly in Europe, with additional installations in...
I am a highly motivated honours graduate with over 12 years’ experience working within the regulated Pharmaceutical industry for the major Blue Chip companies. Specialising in GMP / Quality Compliance with focus on qualification as well as Change Investigation / Management to support Continuous Process Improvement.